Xylocaine Injection, Solution
Product Images NDC 51662-1591

12 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 51662-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S1 (Structure 1)

S1 (Structure 1)
Chemical structure diagram of the active ingredient in XYLOCAINE injection, solution, showing the molecular components and arrangement including aromatic ring and ethyl groups, with HCl indicated.*
FDA Label Image

S2 (Structure 2)

S2 (Structure 2)
Chemical structure diagram depicting the molecular composition of the active ingredient in XYLOCAINE injection solution. The structure shows a benzene ring with hydroxyl groups and an attached side chain indicating the molecular arrangement of the drug component.*
FDA Label Image

P1 (Precautions)

P1 (Precautions)
A data table listing drug classes and examples of drugs in each class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with specific drug names provided under each category.*
FDA Label Image

Max Dose (Max Dose)

Max Dose (Max Dose)
A data table listing various medical procedures alongside corresponding doses (percent and milliliters) and total dose in milligrams for Xylocaine injection solution. The table includes procedures like infiltration, perineural blocks, thoracic, lumbar, cervical nerve blocks, and others, showing dosage variations for the product strengths 10 mg/mL and 20 mg/mL.*
FDA Label Image
FDA Label Image

Rfid Label (51662 1590 1 Rfid)

Rfid Label (51662 1590 1 Rfid)
A close-up image of a label featuring a GS1 DataMatrix barcode and multiple encoded numbers, including the Global Trade Item Number (GTIN) and other identifiers. The label instructs to see the manufacturer's insert and states distribution by HF Acquisition Co., LLC located in Mukilteo, WA 98275. The proprietary name XYLOCAINE and related drug data are not directly visible but associated with the label.*
FDA Label Image

1590 Pouch (1590 Pouch 1)

1590 Pouch (1590 Pouch 1)
XYLOCAINE (Lidocaine HCl) Injection, USP 2% 1000 mg/50 mL (20 mg/mL) 50 mL vial. The label indicates it is for infiltration and nerve block use, not for caudal or epidural use. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. The vial is single-use and sterile with storage instructions at 20°C to 25°C (68°F to 77°F).*
FDA Label Image

1590 Case (1590 Case 1)

1590 Case (1590 Case 1)
XYLOCAINE (Lidocaine HCl Injection) 20 mg/mL solution for injection, 50 mL vial, packaged by HF Acquisition Co LLC, DBA HealthFirst. The label indicates a box containing 25 vials. It includes usage instructions for infiltration and nerve block, storage conditions, and manufacturer information based in Mukilteo, WA.*
FDA Label Image

Rfid Label (51662 1590 3 Rfid)

Rfid Label (51662 1590 3 Rfid)
Label on a pharmaceutical vial showing serialized product identifiers including GTIN and batch codes, with a nearby 2D barcode. The label states distribution by HF Acquisitions Co, LLC in Mukilteo, WA. The product is XYLOCAINE injection solution, a human prescription drug for infiltration and perineural routes.*
FDA Label Image

1591 Pouch (1591 Pouch 1)

1591 Pouch (1591 Pouch 1)
XYLOCAINE (Lidocaine HCl Injection, USP) 1% 20 mg/mL solution for injection in a 20 mL vial. The label includes NDC 51662-1591-2, lot number, expiration date, and manufacturer information by HF Acquisition Co LLC, Mukilteo, WA. The label cautions sterile, nonpyrogenic use and storage at controlled room temperature (68°F to 77°F).*
FDA Label Image

1591 Case (1591 Case 1)

1591 Case (1591 Case 1)
XYLOCAINE (Lidocaine HCl) Injection, USP 1% 200 mg/20 mL (10 mg/mL) 20 mL vial, package of 25. The label includes lot number, expiration date, and handling instructions specifying it is for infiltration and nerve block, not for caudal or epidural use. The manufacturer is HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA. The label also notes that the solution should be clear and colorless, with preservatives and storage conditions detailed.*
FDA Label Image

Rfid Label (51662 1591 3 Rfid)

Rfid Label (51662 1591 3 Rfid)
Top portion of a packaging label for XYLOCAINE injection solution. Visible details include numeric identifiers and a barcode. The label mentions the product is distributed by HF Acquisitions Co., LLC in Mukilteo, WA. The full product name, strengths, and dosage form are not fully shown but are known from the product data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.